呼吸指南

订阅

MedSci主页 / 所有栏目 / 呼吸指南

2020 JRS临床实践指南：睡眠呼吸暂停综合征

2022-01-06 日本呼吸学会 Respir Investig

睡眠呼吸障碍睡眠呼吸障碍综合征

睡眠呼吸障碍（SDB）的患病率非常高，其中睡眠呼吸暂停综合征（OSA）的发病率比之前认为的要搞。本主要针对睡眠呼吸暂停综合征的管理提供指导建议。

中文标题：

2020 JRS临床实践指南：睡眠呼吸暂停综合征

英文标题：

Sleep Apnea Syndrome (SAS) Clinical Practice Guidelines 2020

发布机构：

日本呼吸学会

发布日期：

2022-01-06

简要介绍：

睡眠呼吸障碍（SDB）的患病率非常高，其中睡眠呼吸暂停综合征（OSA）的发病率比之前认为的要搞。本主要针对睡眠呼吸暂停综合征的管理提供指导建议。

 

相关资料下载：
[AttachmentFileName(sort=1, fileName=2020 JRS临床实践指南：睡眠呼吸暂停综合征.pdf)] GetToolGuiderByIdResponse(projectId=1, id=ec5251c00231a0b4, title=2020 JRS临床实践指南：睡眠呼吸暂停综合征, enTitle=Sleep Apnea Syndrome (SAS) Clinical Practice Guidelines 2020, guiderFrom=Respir Investig, authorId=0, author=, summary=睡眠呼吸障碍（SDB）的患病率非常高，其中睡眠呼吸暂停综合征（OSA）的发病率比之前认为的要搞。本主要针对睡眠呼吸暂停综合征的管理提供指导建议。, cover=https://img.medsci.cn/202217/1641555527265_1608702.jpg, journalId=0, articlesId=null, associationId=197, associationName=日本呼吸学会, associationIntro=null, copyright=0, guiderPublishedTime=Thu Jan 06 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>睡眠呼吸障碍（SDB）的患病率非常高，其中睡眠呼吸暂停综合征（OSA）的发病率比之前认为的要搞。本主要针对睡眠呼吸暂停综合征的管理提供指导建议。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=10035, tagName=睡眠呼吸障碍), TagDto(tagId=28538, tagName=睡眠呼吸障碍综合征)], categoryList=[CategoryDto(categoryId=12, categoryName=呼吸, tenant=100), CategoryDto(categoryId=17, categoryName=神经科, tenant=100), CategoryDto(categoryId=30, categoryName=耳鼻咽喉, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=28538, guiderKeyword=睡眠呼吸障碍综合征, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=5, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=41623, appHits=369, showAppHits=0, pcHits=1526, showPcHits=41254, likes=3, shares=34, comments=28, approvalStatus=1, publishedTime=Fri Jan 07 19:30:35 CST 2022, publishedTimeString=2022-01-06, pcVisible=1, appVisible=1, editorId=1608702, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=dajiong, createdTime=Fri Jan 07 19:39:37 CST 2022, updatedBy=1608702, updatedName=dajiong, updatedTime=Sat Jan 06 18:15:33 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 JRS临床实践指南：睡眠呼吸暂停综合征.pdf)])
2020 JRS临床实践指南：睡眠呼吸暂停综合征.pdf
下载请点击：
评论区 (24)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2159926, encodeId=1d0121599260e, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0805237067, createdName=147b1f37m27暂无昵称, createdTime=Tue Sep 26 23:52:33 CST 2023, time=2023-09-26, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2157099, encodeId=91f6215e099da, content=加油, beContent=null, objectType=guider, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd598842662, createdName=ms7000000904555803, createdTime=Mon Sep 11 11:25:28 CST 2023, time=2023-09-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2096081, encodeId=350b20960816c, content=加油, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=008e8395930, createdName=ms8000000873699254, createdTime=Tue Oct 25 17:20:37 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220205, encodeId=27751220205c5, content=加油, beContent=null, objectType=guider, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3da35408927, createdName=ms3000002057134316, createdTime=Tue May 17 08:41:02 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205823, encodeId=dce612058230e, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220325/3cf95d26ec4a4868a63bcc681e37dd4c/00862174d9b74167b2fc276a48282afb.jpg, createdBy=90866571354, createdName=ms9000001897942088, createdTime=Fri Mar 25 11:31:36 CST 2022, time=2022-03-25, status=1, ipAttribution=)]
    2023-09-26 147b1f37m27暂无昵称 来自四川省

    学到了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2159926, encodeId=1d0121599260e, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0805237067, createdName=147b1f37m27暂无昵称, createdTime=Tue Sep 26 23:52:33 CST 2023, time=2023-09-26, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2157099, encodeId=91f6215e099da, content=加油, beContent=null, objectType=guider, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd598842662, createdName=ms7000000904555803, createdTime=Mon Sep 11 11:25:28 CST 2023, time=2023-09-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2096081, encodeId=350b20960816c, content=加油, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=008e8395930, createdName=ms8000000873699254, createdTime=Tue Oct 25 17:20:37 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220205, encodeId=27751220205c5, content=加油, beContent=null, objectType=guider, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3da35408927, createdName=ms3000002057134316, createdTime=Tue May 17 08:41:02 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205823, encodeId=dce612058230e, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220325/3cf95d26ec4a4868a63bcc681e37dd4c/00862174d9b74167b2fc276a48282afb.jpg, createdBy=90866571354, createdName=ms9000001897942088, createdTime=Fri Mar 25 11:31:36 CST 2022, time=2022-03-25, status=1, ipAttribution=)]
    2023-09-11 ms7000000904555803 来自湖南省

    加油

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2159926, encodeId=1d0121599260e, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0805237067, createdName=147b1f37m27暂无昵称, createdTime=Tue Sep 26 23:52:33 CST 2023, time=2023-09-26, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2157099, encodeId=91f6215e099da, content=加油, beContent=null, objectType=guider, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd598842662, createdName=ms7000000904555803, createdTime=Mon Sep 11 11:25:28 CST 2023, time=2023-09-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2096081, encodeId=350b20960816c, content=加油, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=008e8395930, createdName=ms8000000873699254, createdTime=Tue Oct 25 17:20:37 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220205, encodeId=27751220205c5, content=加油, beContent=null, objectType=guider, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3da35408927, createdName=ms3000002057134316, createdTime=Tue May 17 08:41:02 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205823, encodeId=dce612058230e, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220325/3cf95d26ec4a4868a63bcc681e37dd4c/00862174d9b74167b2fc276a48282afb.jpg, createdBy=90866571354, createdName=ms9000001897942088, createdTime=Fri Mar 25 11:31:36 CST 2022, time=2022-03-25, status=1, ipAttribution=)]
    2022-10-25 ms8000000873699254

    加油

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2159926, encodeId=1d0121599260e, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0805237067, createdName=147b1f37m27暂无昵称, createdTime=Tue Sep 26 23:52:33 CST 2023, time=2023-09-26, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2157099, encodeId=91f6215e099da, content=加油, beContent=null, objectType=guider, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd598842662, createdName=ms7000000904555803, createdTime=Mon Sep 11 11:25:28 CST 2023, time=2023-09-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2096081, encodeId=350b20960816c, content=加油, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=008e8395930, createdName=ms8000000873699254, createdTime=Tue Oct 25 17:20:37 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220205, encodeId=27751220205c5, content=加油, beContent=null, objectType=guider, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3da35408927, createdName=ms3000002057134316, createdTime=Tue May 17 08:41:02 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205823, encodeId=dce612058230e, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220325/3cf95d26ec4a4868a63bcc681e37dd4c/00862174d9b74167b2fc276a48282afb.jpg, createdBy=90866571354, createdName=ms9000001897942088, createdTime=Fri Mar 25 11:31:36 CST 2022, time=2022-03-25, status=1, ipAttribution=)]
    2022-05-17 ms3000002057134316

    加油

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2159926, encodeId=1d0121599260e, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0805237067, createdName=147b1f37m27暂无昵称, createdTime=Tue Sep 26 23:52:33 CST 2023, time=2023-09-26, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2157099, encodeId=91f6215e099da, content=加油, beContent=null, objectType=guider, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd598842662, createdName=ms7000000904555803, createdTime=Mon Sep 11 11:25:28 CST 2023, time=2023-09-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2096081, encodeId=350b20960816c, content=加油, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=008e8395930, createdName=ms8000000873699254, createdTime=Tue Oct 25 17:20:37 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220205, encodeId=27751220205c5, content=加油, beContent=null, objectType=guider, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3da35408927, createdName=ms3000002057134316, createdTime=Tue May 17 08:41:02 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205823, encodeId=dce612058230e, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220325/3cf95d26ec4a4868a63bcc681e37dd4c/00862174d9b74167b2fc276a48282afb.jpg, createdBy=90866571354, createdName=ms9000001897942088, createdTime=Fri Mar 25 11:31:36 CST 2022, time=2022-03-25, status=1, ipAttribution=)]
    2022-03-25 ms9000001897942088

    谢谢分享

    0

以上为热门评论，梅斯医学App还有更多内容

相关指南

2021 ERS指南：阻塞性睡眠呼吸暂停的非CPAP治疗

欧洲呼吸学会(ERS,European Respiratory Society) · 2021-11-30

2021 BC指南：成人阻塞性睡眠呼吸暂停的评估和管理

不列颠哥伦比亚省临床实践指南中心(BC,Clinical Practice Guidelines and Protocols in British Columbia) · 2021-10-21

美国睡眠医学会临床实践指南：将阻塞性睡眠呼吸暂停成人转诊至外科会诊

美国睡眠医学会(AASM,American Academy of Sleep Medicine) · 2021-08-05

将阻塞性睡眠呼吸暂停成人转诊至外科会诊：美国睡眠医学会系统评价、荟萃分析和 GRADE 评估

美国睡眠医学会(AASM,American Academy of Sleep Medicine) · 2021-08-15

2016 国际老年睡眠医学工作组共识：老年人以及体弱老年人睡眠呼吸障碍的治疗

国际老年睡眠医学工作组(International Geriatric Sleep Medicine Task Force) · 2016-07-28

拓展阅读

老年睡眠呼吸暂停综合征诊断评估专家共识

中国老年医学学会睡眠医学分会 · 2022-03-23